Skip to content

Sera Prognostics SERA Other accrued liabilities

Other accrued liabilities at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
GRAIL, Inc. logo
GRAIL, Inc.GRAL

Other financials

Income statement

See full
Revenue$14.0K-63.2%
Operating income-$9.4M-1.2%
Net income-$8.4M-2.6%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$4.2M-20.2%
Total debt$2.5M+286%
Total equity$67.6M-28.7%
Total assets$93.5M-20.8%

Cash flow

See full
Operating cash flow-$8.8M-16.2%
CapEx$8.0K+167%
Free cash flow-$8.8M-16.2%

Valuation

See full
Market cap$71.27M+5.0%
Enterprise value$69.6M+9.6%
P/S1,250.3×+622×

Profitability

See full
Operating margin-64,235.1%-8,092,342pp
Net margin-56,386%+1,586,573pp
FCF margin-48,377.2%-673,104pp

Returns & leverage

See full
Return on equity-39.6%-1.6pp
Debt / equity0.0×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by Sera Prognostics in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sera Prognostics's other accrued liabilities?
Sera Prognostics (SERA) reported other accrued liabilities of $854K in Q1 2026.
How has Sera Prognostics's other accrued liabilities changed year-over-year?
Sera Prognostics's other accrued liabilities increased by 111.9% year-over-year, from $403K to $854K.
What is the long-term trend for Sera Prognostics's other accrued liabilities?
Over 5 years (2020 to 2025), Sera Prognostics's other accrued liabilities has grown at a 10.9% compound annual growth rate (CAGR), from $191K to $320K.